Health ❯ Neurology

Multiple Sclerosis

Symptoms Patient Care Risk Factors Treatment Options Clinical Development Treatment Methods Cognitive Performance Inflammation Treatment Therapeutic Approaches Cognition Prodromal Phase Clinical Research Disease Prevention Cell Biology Estrogen Research Brain Function Drug Applications Diagnosis Disease Progression Cannabis Use Prevalence Chronic Spontaneous Urticaria

Novartis Moves to File Oral MS Drug After Phase‑3 Win as Separate CAR‑T Trials Are Paused

Remibrutinib’s superior late‑stage results open a regulatory path for a new oral therapy for relapsing MS.

Roche and Nurix Strike $700M Deal to Co‑Develop Oral BTK Degrader Bexobrutideg

Study Links Early Menopause to Higher Dementia Risk as HRT Use Correlates With Lower Risk

Largest Study Finds Menopause Does Not Accelerate Disability in Women With MS